Abstract
ABSTRACTThe oral-sustained release dosage form containing Repaglinide (RPG, antidiabetic) and Diltiazem HCL (DIL, antihypertensive) loaded chitosan nanoparticles were prepared by the ionotropic gelation method. The chitosan concentration (A) and TPP concentration (B) were selected as independent variables while percentage drug loading of Repaglinide (Y1) and Diltiazem HCL (Y2) were chosen as the dependent variables. The RPG and DIL-loaded chitosan nanoparticles produced in this study were evaluated for drug-polymer interaction, surface morphology, encapsulation efficiency, drug loading, particle size and invitro drug release. The release of Repaglinide from the drug-loaded nanoparticles in a phosphate buffer (pH 7.4) solution was observed to be sustained over a period of 19 h (batch1) while Diltiazem showed sustained release behaviour over a period of 20 h in distilled water. FTIR analysis confirmed compatibility of the drug with excipients. Apparent particle size data showed that the particles were nano size with a low polydispersity index.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
